Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients

BACKGROUND: Hypercalcemia of malignancy (HCM) is a serious metabolic complication, and the highest rates are in multiple myeloma (MM). The cause of hypercalcemia in newly diagnosed multiple myeloma (NDMM) remains unknown. We sought to evaluate the prognostic impact and mechanism of hypercalcemia in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Li, Wang, Yutong, Lu, Minqiu, Chu, Bin, Shi, Lei, Gao, Shan, Fang, Lijuan, Xiang, Qiuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724491/
https://www.ncbi.nlm.nih.gov/pubmed/33145966
http://dx.doi.org/10.1002/cam4.3594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724491/
https://www.ncbi.nlm.nih.gov/pubmed/33145966
http://dx.doi.org/10.1002/cam4.3594

Ejemplares similares